drugset / Trial / NCT00349180
Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is performed to confirm the optimal dose for THR (total hip replacement).
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 20 mg | — |